The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Market Size Of The Novel Drug Delivery Systems Market In 2026 And What Value Is Projected For 2030?
The novel drug delivery systems market has shown rapid expansion in recent years. It is anticipated to expand from $117.66 billion in 2025 to $129.45 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.0%. The increase observed in previous periods can be linked to several factors, including the rising occurrence of chronic illnesses, the limitations inherent in conventional drug administration methods, an expanding pipeline in oncology and biologics, escalating healthcare spending, and breakthroughs in polymer and nanotechnology.
The novel drug delivery systems market is anticipated to experience substantial expansion in the coming years, with projections indicating it will reach $187.53 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 9.7%. This growth during the forecast period stems from factors such as a rise in personalized and precision medicine, increased demand for targeted cancer treatments, greater investment in pharmaceutical R&D, the broadening scope of biologics and biosimilars, and favorable regulatory backing for innovative drug delivery technologies. Key trends observed within this period encompass the wider application of targeted and personalized drug delivery, increasing use of lipid and polymeric nanoparticles, advancements in long-acting and controlled-release formulations, a heightened emphasis on non-invasive and patient-friendly delivery methods, and intensified R&D efforts in combined and hybrid novel drug delivery systems platforms.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25850&type=smp
What Drivers Are Influencing The Novel Drug Delivery Systems Market?
The increasing incidence of neurological conditions is projected to boost expansion in the novel drug delivery systems market in the future. A neurological condition, like a stroke, represents a medical state where there is an abrupt loss of neurological function caused by an interruption of blood flow to the brain, either from an obstruction (ischemic stroke) or a burst blood vessel (hemorrhagic stroke), resulting in brain tissue damage and potentially enduring cognitive, sensory, or motor deficits. The growing occurrence of neurological disorders is primarily fueled by elements such as an aging demographic, a rise in lifestyle-associated ailments like high blood pressure, diabetes, and obesity, along with elevated exposure to persistent stress and environmental hazards. Advanced drug delivery systems aid in managing neurological disorders by facilitating the precise and regulated administration of therapeutic agents across the blood-brain barrier. As an example, in November 2024, data from the National Health Service (NHS) England, a UK healthcare provider, indicated that stroke admissions in England climbed to 111,137 during 2023/24, with the 50–59 age demographic showing the most significant rise at 12,533 cases. Consequently, the escalating number of neurological disorder cases is propelling the expansion of the novel drug delivery systems market.
What Are The Key Segments Of The Novel Drug Delivery Systems Market?
The novel drug delivery systems market covered in this report is segmented –
1) By Formulation Type: Liposomes, Nanoparticles, Microspheres, Hydrogels, Dendrimers
2) By Mode Of Novel Drug Delivery System (NDDS): Targeted Drug Delivery Systems, Controlled Drug Delivery Systems, Modulated Drug Delivery Systems
3) By Route: Oral Drug Delivery Systems, Injectable Drug Delivery Systems, Pulmonary Drug Delivery Systems, Transdermal Drug Delivery Systems, Other Routes
4) By Therapeutic Area: Cancer, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Autoimmune Diseases
5) By End-User: Hospital, Specialty Clinics, Research Centers, Other End-Users
Subsegments:
1) By Liposomes: PEGylated Liposomes, Cationic Liposomes, Stealth Liposomes, Immunoliposomes
2) By Nanoparticles: Polymeric Nanoparticles, Lipid Nanoparticles, Metallic Nanoparticles, Nanocrystals
3) By Microspheres: Biodegradable Microspheres, Magnetic Microspheres, Radioactive Microspheres, Mucoadhesive Microspheres
4) By Hydrogels: Thermosensitive Hydrogels, Ph-Responsive Hydrogels, Injectable Hydrogels, Smart Hydrogels
5) By Dendrimers: PAMAM Dendrimers, PPI Dendrimers, Pegylated Dendrimers, Hybrid Dendrimers
What Key Trends Are Influencing The Development Of The Novel Drug Delivery Systems Market?
Major companies operating in the novel drug delivery systems market are concentrating on creating innovative solutions, such as oral thin films, to enhance patient adherence and the effectiveness of therapies. An oral thin film is a drug delivery system consisting of a rapidly dissolving film strip applied in the oral cavity, designed to release medication directly into the bloodstream via the mucosal membrane. For instance, in February 2024, CD Formulation, a US-based pharmaceutical formulation company, launched Oral Thin Film Technology. This product facilitates rapid drug absorption by bypassing gastrointestinal and liver metabolism, making it particularly suitable for patients experiencing swallowing difficulties. It also supports accurate dosing and a faster onset of action, thereby enhancing treatment precision and convenience across various therapeutic applications.
Who Are The Leading Companies Operating In The Novel Drug Delivery Systems Market?
Major companies operating in the novel drug delivery systems market are Pfizer Inc, Johnson And Johnson, F Hoffmann La Roche AG, Merck And Co Inc, AbbVie Inc, Bayer AG, Sanofi SA, Bristol Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly And Company, Gilead Sciences, Amgen Inc, Teva Pharmaceutical Industries Ltd, Otsuka Pharmaceutical Co Ltd, Regeneron Pharmaceuticals, Samyang Holdings Corporation, Galen Limited, Catalent Inc, Evonik Industries AG
Read the full novel drug delivery systems market report here:
https://www.thebusinessresearchcompany.com/report/novel-drug-delivery-systems-global-market-report
Which Regions Are Expected To Experience Rapid Expansion In The Novel Drug Delivery Systems Market?
North America was the largest region in the novel drug delivery systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the novel drug delivery systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Novel Drug Delivery Systems Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=25850&type=smp
Browse Through More Reports Similar to the Global Novel Drug Delivery Systems Market 2026, By The Business Research Company
Electronic Drug Delivery Systems Market Report 2026
Pharmaceutical Drug Delivery Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report
Smart Drug Delivery Systems Market Report 2026
https://www.thebusinessresearchcompany.com/report/smart-drug-delivery-systems-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model